Clinical Trials

RECRUITING NOW:

"Effects of Bexarotene on Cognition and Alzheimer's Disease Spinal Fluid Biomarkers in Elderly Patients with Cutaneous Lymphoma"

Stanford-only, investigator-initiated study

Subjects: 60 years of age or older, diagnosis of cutaneous lymphoma, about to start treatment with bexarotene

Contact: If you are interested in participating, please contact Christina Wyss-Coray, RN, by email or at 650-721-2409

COMING SOON:

"A Randomized, Double-Blinded, Placebo-Controlled Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB037 in Subjects with Prodromal or Mild Alzheimer’s Disease"

Sponsor: Biogen Idec

Subjects: 55-90 years old, diagnosis of prodromal Alzheimer's disease (Mild Cognitive Impairment) or mild Alzheimer's disease

Contact: If you are interested in participating, please contact Christina Wyss-Coray, RN, by email or at 650-721-2409

ClinicalTrials.gov Listing: NCT01397539

ONGOING, CLOSED TO RECRUITMENT:

"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase II Study to Evlaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease"

Sponsor: Genentech

Subjects: 50-80 years old, diagnosis of Alzheimer's disease

ClinicalTrials.gov Listing: NCT0139757